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REVIEW
Use of zebrafish to study Shigella infection
Gina M. Duggan and Serge Mostowy*
ABSTRACT
Shigella is a leading cause of dysentery worldwide, responsible for
up to 165 million cases of shigellosis each year. Shigella is also
recognised as an exceptional model pathogen to study key issues in
cell biology and innate immunity. Several infection models have been
useful to explore Shigella biology; however, we still lack information
regarding the events taking place during the Shigella infection
process in vivo. Here, we discuss a selection of mechanistic insights
recently gained from studying Shigella infection of zebrafish (Danio
rerio), with a focus on cytoskeleton rearrangements and cellular
immunity. We also discuss how infection of zebrafish can be used to
investigate new concepts underlying infection control, including
emergency granulopoiesis and the use of predatory bacteria to
combat antimicrobial resistance. Collectively, these insights illustrate
how Shigella infection of zebrafish can provide fundamental
advances in our understanding of bacterial pathogenesis and
vertebrate host defence. This information should also provide vital
clues for the discovery of new therapeutic strategies against
infectious disease in humans.
KEY WORDS: Antimicrobial resistance, Autophagy, Cytoskeleton,
Emergency granulopoiesis, Inflammation, Macrophage, Neutrophil,
Septin, Shigella, Zebrafish
Introduction
Shigella are a pathovar (see Glossary, Box 1) of Escherichia coli
that cause dysentery (see Glossary, Box 1) via inflammatory
destruction of the intestinal epithelium, a disease process called
shigellosis. Up to 165 million cases of shigellosis are estimated to
occur annually, resulting in up to half a million deaths (Lima et al.,
2015; Kotloff et al., 2017). Moreover, Shigella infection can give
rise to serious postinfectious sequelae (see Glossary, Box 1), such as
arthritis, sepsis, seizures and haemolytic uremic syndrome (see
Glossary, Box 1). Similar to other Gram-negative (see Glossary,
Box 1) pathogens, cases of Shigella with acquired resistance to
fluoroquinolones (see Glossary, Box 1) and other antibiotics are
rising (Harrington, 2015), and the World Health Organization
(WHO) has listed Shigella among its top 12 priority pathogens
requiring urgent action (WHO report, 2017). Among the four
Shigella subgroups, Shigella flexneri is the most common cause of
dysentery in low-income countries and the most prevalent of the
Shigella subgroups in children under 5 years of age (Connor et al.,
2015). By contrast, infection from Shigella sonnei predominates in
developed countries (Kotloff et al., 1999; Holt et al., 2012; Kotloff
et al., 2017). The infection process of S. sonnei remains poorly
understood compared to that of S. flexneri, and therefore the
majority of our current knowledge is extrapolated from work
performed using S. flexneri. Important differences between
subgroups have been described genetically, but have not been
fully tested in infection models, for example the presence of a
chromosomally encoded type VI secretion system (T6SS; see
Glossary, Box 1) in S. sonnei, which is absent in S. flexneri.
In addition to being an urgent health threat, S. flexneri is
recognised as a paradigm for the investigation of cell biology and
innate immunity (Picking and Picking, 2016). Through decades of
work performed in vitro using the infection of cultured cells,
Shigella has been a valuable model for dissecting how bacteria can
invade nonphagocytic cell types (Cossart and Sansonetti, 2004;
Haglund and Welch, 2011), form actin tails (see Glossary, Box 1)
for cell-to-cell spread (Haglund and Welch, 2011; Welch and Way,
2013), and be recognised by cellular immunity (see Glossary,
Box 1) for host defence (Phalipon and Sansonetti, 2007; Ashida
et al., 2011, 2015). In an effort to fully decipher the molecular and
cellular mechanisms underlying the Shigella infection process, the
field is progressively shifting towards in vivo investigation using
relevant animal models.
The zebrafish infection model
To date, our capability of understanding the Shigella infection
process in vivo has been limited. Although no nonprimate animal
model exists that closely mimics shigellosis in humans, a variety of
steps underlying the Shigella infection process can be examined
using the rabbit (Arm et al., 1965; Perdomo et al., 1994; Schnupf
and Sansonetti, 2012), guinea pig (Sereny, 1955; Shim et al., 2007)
and mouse models (Yang et al., 2014; Li et al., 2017). Although
these mammalian models have provided significant advances in
testing mechanisms underlying Shigella pathogenesis, they remain
poorly suited for in vivo imaging of the cell biology of Shigella
infection.
There are many advantages to using zebrafish larvae (see
Glossary, Box 1) to study infection, including their rapid
development, fully annotated genome (which is highly
homologous to that of humans) and optical accessibility for
noninvasive real-time imaging (Lieschke and Currie, 2007;
Sullivan et al., 2017). Importantly, zebrafish larvae lack an
adaptive immune system during early embryonic development,
and thus allow specific study of innate immunity without cross-
interference from the adaptive immune system (Lieschke and Trede,
2009). The zebrafish model is also genetically tractable, and
therefore amenable to the generation of fluorescent transgenic
lines and to targeted gene manipulation. In the case of transient
depletion, gene manipulation can be achieved using morpholino
oligonucleotides (see Glossary, Box 1; Li et al., 2016). However,
morpholinos can elicit off-target effects, and alternative strategies
might be required to validate the conclusions. In the case of
stable genome editing, mutants can be efficiently generated using
zinc finger nucleases (ZFNs) (Foley et al., 2009), transcription
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activator-like effector nucleases (TALENs) (Bedell et al., 2012), or
clustered regulatory interspaced short palindromic repeats/CRISPR-
associated protein 9 (CRISPR/Cas9; see Glossary, Box 1; Blum
et al., 2015). These systems all induce a site-specific double-
stranded break, repaired using a nonhomologous end joining
mechanism (Ata et al., 2016). The CRISPR/Cas9 system is
currently the most prevalent approach to generate zebrafish mutants.
In recent years, our understanding of the infection process has
expanded considerably through the use of the zebrafish infection
model (reviewed in Renshaw and Trede, 2012). Originally used to
study Mycobacterium marinum, a natural fish pathogen closely
related to Mycobacterium tuberculosis (see Glossary, Box 1),
zebrafish larvae have since been exploited to study pathogenesis
and infection biology using a wide variety of bacteria (Masud
Box 1. Glossary
Actin tails: Propulsive tails that result from the polymerisation of the host cell actin by intracytosolic pathogens to aid them in disseminating from cell-to-cell.
ASC speck: A platform for caspase-1 activity and readout for inflammasome activation.
Autophagosome: Double-membraned vesicle that compartmentalises cellular material targeted to autophagy.
Autophagy: A highly coordinated process of intracellular degradation whereby cytosolic components are isolated within a double-membrane vacuole
(autophagosome) and targeted for lysosomal destruction.
Bdellovibrio bacteriovorus: A Gram-negative bacterium that parasitises other Gram-negative bacteria by invading their periplasmic space, undergoing
replication, and killing their prey.
Caspase: Cysteine protease controlling inflammation and programmed cell death.
Cell-autonomous immunity: The ability of a host cell to independently eliminate infectious agents using antimicrobial defences and host cell death.
CRISPR/Cas9: A genome editing approach adapted from the antibacteriophage defence system discovered in bacteria.
Cytokinetic furrow: A micron-scale invagination of the cellular surface during cytokinesis, leading to cell division.
Dysentery: Gastroenteritis resulting in bloody diarrhoea.
E3 ubiquitin ligase: Ligating (E3) enzymes that, together with ubiquitin activating (E1) and conjugating (E2) enzymes, mediate ubiquitylation (a post-
translational modification of proteins).
Emergency granulopoiesis: De novo generation of neutrophils that arise from increased myeloid progenitor cell proliferation in response to infection and
leukocyte exhaustion.
Haemolytic uremic syndrome: A life-threatening condition caused by the destruction of red blood cells.
Fluoroquinolones: A family of broad spectrum antibacterial agents used in human and veterinary medicine.
Gram-negative bacteria: A group of bacteria that lose the Crystal Violet dye in the Gram’s method of staining owing to the structure of their cell wall.
Guanylate-binding proteins: A family of GTPases induced by IFNγ, and key components of cellular immunity.
Haematopoietic stem and progenitor cells: Cells that proliferate (into haematopoietic stem cells) and differentiate (into neutrophils) to mediate
emergency granulopoiesis.
Inflammasome: A multi-protein complex and component of the innate immune system that promotes the maturation of inflammatory cytokines through
recruitment of Caspase-1.
Interferon regulatory factor 8: A transcription factor required for lineage commitment and myelopoiesis.
Larva: The juvenile form zebrafish undergo before developing into adults.
Macropinocytosis: A nonselective, actin-dependent mechanism of cellular uptake whereby plasma membrane protrusions fold inwards to form vesicles
(termed macropinosomes).
Mammalian target of rapamycin: A highly conserved kinase used by cells for nutrient sensing.
Metronidazole: A pro-drug used on transgenic fish (engineered to express nitroreductase using a cell/tissue-specific promoter) to ablate specific cells/
tissues.
Morphant: An organism which has been genetically manipulated using morpholino oligonucleotides.
Morpholino oligonucleotide: ∼25 base nucleic acid analogues that affect RNA maturation or translation by sequence-specific base-pairing.
Mycobacterium leprae: A species of bacteria that is the causative agent of leprosy in humans.
Mycobacterium tuberculosis: A species of bacteria that is the causative agent of tuberculosis in humans.
Neural Wiskott-Aldrich syndrome protein: Induces actin polymerisation through the actin-related protein (Arp2/3) complex; it is a specific ligand for Shigella
IcsA.
Neutropenia: A condition in which neutrophil number is decreased.
Neutrophil extracellular traps:Net-like structures comprised largely of decondensed chromatin that are released by neutrophils at sites of acute or chronic
inflammation.
Nonmuscle myosin II: Actin-binding protein with contractile properties.
Orthologues: Genes in different species that evolved from a common ancestral gene.
Paralogues: Two or more genes that derive from the same ancestral gene, originating via genetic duplication.
Pathovar: Bacterial strains with similar characteristics.
Peptidoglycan: A polymer of amino acids and sugars that comprises the bacterial cell wall.
Phagocytic cup: A micron-scale cup-shaped invagination of the cell membrane formed during phagocytosis.
Phagocytosis: A process by which cells engulf particles, including bacterial pathogens.
Prostaglandin D2: A type of lipid signalling molecule produced at sites of tissue damage or infection to control inflammation.
Pyroptosis: A highly inflammatory form of programmed cell death that can occur in response to the presence of intracellular bacteria.
Salmonella enterica serovar Typhimurium: A zoonotic (transmitted from animals) pathogen that causes gastroenteritis and inflammation of the intestinal
mucosa.
Septins: A highly conserved family of GTP binding proteins that interact with the membrane and actin to form higher-order structures including filaments,
rings and cages.
Sequelae: Chronic conditions resulting from infection or injury.
Tumour necrosis factor: A monocyte-derived pleiotropic pro-inflammatory cytokine involved in a spectrum of biological processes, such as induction of
apoptosis.
Type III secretion system: Amembrane embedded needle-like structure present in Gram-negative bacteria used to inject effector proteins into a host cell.
Type VI secretion system: A contractile nanomachine used by Gram-negative bacteria to puncture target cells and deliver effectors.
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et al., 2017; Torraca and Mostowy, 2017), viruses (Levraud et al.,
2014; Varela et al., 2017) and fungi (Gratacap andWheeler, 2014;
Yoshida et al., 2017). For this purpose, injection of bacteria in the
caudal vein/posterior blood island or Duct of Cuvier has been
used to investigate systemic infection responses (Fig. 1), whereas
injection in the tail muscle or hindbrain ventricle (HBV) has
been used to analyse a directed leukocyte response to a
compartmentalised infection (Fig. 1). Zebrafish infection
models have been developed to study a variety of
enteropathogens. For example, injection of Salmonella enterica
serovar Typhimurium (see Glossary, Box 1) into zebrafish has
been key for discovery of novel concepts in cellular immunity,
immunometabolism, and emergency granulopoiesis (see
Glossary, Box 1; reviewed in Torraca and Mostowy, 2017).
Recent work has established zebrafish as a model for foodborne
enterohaemorrhagic E. coli (EHEC) infection (Stones et al.,
2017), a major cause of diarrhoeal illness in humans. Using the
protozoan Paramecium caudatum as a vehicle for EHEC delivery,
work has shown that zebrafish larvae can be used to study the
hallmarks of human EHEC infection, including EHEC-phagocyte
interactions in the gut and bacterial transmission to naive hosts
(Stones et al., 2017). In the case of Shigella, caudal vein infection
of zebrafish was first developed to study Shigella-phagocyte
interactions and bacterial autophagy (see Glossary, Box 1) in vivo
(Mostowy et al., 2013). Strikingly, many hallmarks of shigellosis
observed in humans, including epithelial cell invasion,
macrophage cell death and inflammation, are reproduced in a
zebrafish model of S. flexneri infection, and are strictly dependent
upon the Shigella type III secretion system (T3SS; see Glossary,
Box 1). Moreover, studies using this model discovered a
scavenger role for neutrophils in eliminating infected
macrophages and other cell types that fail to control Shigella
infection (Mostowy et al., 2013). In this case, when infected
macrophages and other cell types fail to control infection,
scavenger neutrophils act as a compensatory mechanism to clear
both the dead macrophages and the infection.
Collectively, these reports introduced the zebrafish as a
novel animal model to study the cell biology and innate immune
response to Shigella at the molecular, cellular and whole-animal
levels. In this Review, we highlight the diverse applications of
Shigella-zebrafish infection, discussing the progress and insights
achieved to date. We also discuss several open questions and future
prospects.
Recent mechanistic insights into Shigella infection
Here, we summarise a selection of mechanistic insights recently
gained from studying Shigella infection of zebrafish. We focus on
examples from two main themes: cytoskeleton rearrangements
during infection, a historically important field of study critical for
our understanding of host-pathogen interactions, and cellular
immunity, a rapidly evolving field important for understanding
host defence. These new mechanistic insights significantly expand
our knowledge of the host response to Shigella infection, and also
shed light on the general mechanisms crucial for host defence
against bacterial pathogens.
Cytoskeleton rearrangements during Shigella infection
Investigation of the cytoskeleton during bacterial infection has
enabled major discoveries in both infection and cell biology
(Cossart and Sansonetti, 2004; Haglund and Welch, 2011; Welch
and Way, 2013). For example, how pathogens manipulate the host
cytoskeleton to gain entry into cells and polymerise actin tails has
revolutionised our understanding of phagocytosis (see Glossary,
Box 1) and cell motility (Cossart and Sansonetti, 2004; Haglund and
Welch, 2011; Welch and Way, 2013). In this section, we review the
host cell response to Shigella invasion and actin-based motility, and
discuss what has recently been learned from investigation using
zebrafish.
Shigella uptake into nonphagocytic cells has been well
characterised in vitro, where entry is dependent upon injection of
T3SS effector proteins into the host cell (reviewed in Cossart and
Sansonetti, 2004). This form of bacterial uptake, called trigger-
mediated entry, causes the reorganisation of the host cell
cytoskeleton via actin remodelling and plasma membrane ruffling
(Fig. 2A). Engulfment occurs by a process analogous to
macropinocytosis (see Glossary, Box 1), and, in the case of
Shigella, is followed by vacuolar rupture and escape of bacteria into
the cytosol (Weiner et al., 2016). Once in the cytosol, Shigella can
recruit neural Wiskott-Aldrich syndrome protein (N-WASp; see
Glossary, Box 1) to polymerise actin tails for its own motility
(Fig. 2B), a process dependent on the bacterial outer membrane
autotransporter IcsA (Goldberg and Theriot, 1995). Studies using
Fig. 1. Different injection sites of zebrafish larvae used to study Shigella infection. Main attributes of different injection sites used for the study of Shigella
infection of zebrafish larvae (3 days postfertilisation). To study systemic infection and Shigella-phagocyte interactions, intravenous injection of Shigella into the
circulation is performed via the caudal vein/posterior blood island or Duct of Cuvier (highlighted in red). To study compartmentalised infection and a directed
leukocyte response to Shigella, injection of Shigella into the hindbrain ventricle, or subcutaneous/intramuscular injection of Shigella into epithelial cells of the tail
muscle, is used (highlighted in green). The dashed line boxes indicate the aorta-gonad-mesonephros (AGM) and caudal hematopoietic tissue (CHT) where
emergency granulopoiesis (see Glossary, Box 1) takes place.
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human epithelial cells have discovered key roles for septins (see
Glossary, Box 1) in the regulation of actin-mediated infection
processes (reviewed in Torraca and Mostowy, 2016). A relatively
poorly understood component of the cytoskeleton compared to
actin, septins are important for a variety of cellular processes
including cytokinesis and host-pathogen interactions (reviewed in
Saarikangas and Barral, 2011;Mostowy and Cossart, 2012). Septins
are highly conserved in vertebrates, and in humans are categorised
into four groups (called the SEPT2, SEPT3, SEPT6 and SEPT7
groups), the products of which assemble into hetero-oligomeric
complexes, filaments and ring-like structures. Septins can recognise
areas of micron-scale curvature, including the cytokinetic furrow
(see Glossary, Box 1) and phagocytic cup (see Glossary, Box 1),
where they act both as scaffolds for protein recruitment
and as diffusion barriers for subcellular compartmentalisation
(Saarikangas and Barral, 2011; Mostowy and Cossart, 2012;
Bezanilla et al., 2015; Cannon et al., 2017). Consistent with this,
new work has shown that septins in neurons contribute to cell shape
memory (Boubakar et al., 2017) and the maturation of dendritic
spines (Yadav et al., 2017).
During Shigella infection, septins are recruited to the phagocytic
cup alongside actin and form rings around invading bacterium
(Mostowy et al., 2009a,b). Although the precise role of septins during
bacterial entry is not clear, the depletion of SEPT2 by small
interfering (si)RNA significantly reduces Shigella entry into host
cells (Mostowy et al., 2009a). Following bacterial escape from the
phagosome to the cytosol, septins are recruited to actin-polymerising
bacteria, forming cage-like structures around Shigella that inhibit cell-
cell spread, in a process called septin caging (Mostowy et al., 2010).
The depletion of SEPT2, SEPT9 or nonmuscle myosin II (see
Glossary, Box 1) inhibits septin caging and increases the number of
bacteria with actin tails, whereas increasing SEPT2-nonmuscle
myosin II interactions using tumour necrosis factor (TNF; see
Glossary, Box 1) increases septin caging and prevents the formation
of actin tails (Mostowy et al. 2010). Importantly, septin cages have
been observed in zebrafish cells in vitro, as well as in vivo (Fig. 2C),
supporting their role as an evolutionarily conserved host defence
assembly (Mostowy et al., 2013).
The investigation of septins in vivo using mouse models has been
challenging, considering that their deletion can often result in
embryonic lethality (reviewed in Kinoshita and Noda, 2001;
Mostowy and Cossart, 2012). However, developmental studies
using zebrafish have linked the depletion of some septins (i.e. Sept6,
Sept9a, Sept9b, Sept15) to growth defects and aberrant left-right
asymmetry (Landsverk et al., 2010; Dash et al., 2014, 2016; Zhai
et al., 2014). Zebrafish septins have also been shown to play a
Fig. 2. The hallmarks of Shigella infection. (A) Trigger-mediated entry by Shigella. HeLa cells were infected with Shigella (blue), fixed for fluorescent
microscopy, and labelled with antibodies to SEPT9 (red) and phalloidin for F-actin (green) to highlight septin recruitment at the site of Shigella entry. Scale bar:
1 µm. (B) The Shigella actin tail. HeLa cells were infected with Shigella (blue; white arrowhead indicates a motile bacterium) for 3 h, fixed for fluorescent
microscopy, and labelled with antibodies to SEPT2 (red) and phalloidin for F-actin (green) to highlight septin ring formation around the actin tails. Scale bar: 1 µm.
(C) The Shigella-septin cage in vivo. SEPT7 (red) assembles into cage-like structures around S. flexneri (green). Zebrafish larvae were infected with green
fluorescent protein (GFP)-Shigella for 4 h, fixed, labelled with antibodies to SEPT7 and imaged by confocal microscopy. The inset shows a higher magnification
view of the boxed region in C, showing Shigella entrapped within a septin cage. Scale bar: 5 µm. (D) An autophagosome sequestering cytosolic Shigella in vivo.
Zebrafish larvae were infected in the tail muscle with GFP-Shigella for 4 h and fixed for electron microscopy. The inset shows a higher magnification view of the
boxed region in D, showing the double membrane, a hallmark of autophagosomes. Scale bar: 0.25 µm. Images adapted from Mostowy and Cossart (2009) (A),
Mostowy et al. (2010) (B) and Mostowy et al. (2013) (C,D).
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crucial role during S. flexneri infection (Mazon-Moya et al., 2017).
In this case, depletion of Sept15 or Sept7b [zebrafish orthologues
(see Glossary, Box 1) of human SEPT7] significantly increases host
susceptibility both to compartmentalised (HBV) and systemic
(caudal vein) Shigella infection. Live-cell imaging of Sept15-
depleted larvae during infection revealed a failure of neutrophils to
control infection. Susceptibility of septin morphants (see Glossary,
Box 1) to infection is strictly dependent on the Shigella T3SS, as
infection with T3SS-deficient S. flexneri is equally controlled by
control or Sept15 morphants (Mazon-Moya et al., 2017). Sept15
morphants also exhibit neutropenia (see Glossary, Box 1; Mazon-
Moya et al., 2017), a marker of poor prognosis of infection in
humans. These data are consistent with experiments using Sept7-
deficient transgenic mice showing impaired granulopoietic potential
of myeloid progenitors (Menon et al., 2014). The use of
morpholinos to target interferon regulatory factor 8 (Irf8; see
Glossary, Box 1) and boost neutrophil numbers in Sept15
morphants failed to improve the outcome from Shigella infection,
suggesting a cell-autonomous defect of neutrophils with
nonfunctional Sept15 (Mazon-Moya et al., 2017). Collectively,
studies of zebrafish infection with Shigella illustrate a new role for
septins in host defence against bacterial infection, and highlight the
crucial role of the cytoskeleton in neutrophil development and
behaviour.
Cellular immunity to Shigella infection
Shigella has emerged as a model pathogen to investigate how
bacteria can be recognised by, or escape from, the host immune
system (reviewed in Phalipon and Sansonetti, 2007; Ashida et al.,
2011, 2015). For example, studies using Shigella have helped to
discover major roles for nucleotide-binding oligomerisation domain
(NOD)-like receptors (NLRs) (Girardin et al., 2003), bacterial
autophagy (Ogawa et al., 2005) and inflammasomes (see Glossary,
Box 1; Willingham et al., 2007) in host defence. This section will
discuss cellular immunity to Shigella, and how this knowledge has
evolved following recent in vivo studies using zebrafish.
Shigella-autophagy interactions
Discovered as a nutrient recycling process in response to starvation
(reviewed in Yang and Klionsky, 2010), autophagy is also a
selective process crucial for cellular immunity (reviewed in Levine
et al., 2011). During Shigella infection, cytosolic bacteria are
recognised by the autophagy machinery and targeted for lysosomal
delivery (Ogawa et al., 2005). The cytoskeleton, well known for its
role in bacterial invasion and motility, also plays an important role
during the autophagy response to bacteria (reviewed in Mostowy,
2014; Mostowy and Shenoy, 2015). Work using human epithelial
cells has shown that septin cages colocalise with ubiquitylated
proteins that concentrate around autophagy-targeted Shigella
(Mostowy et al., 2010). Consistent with the notion that septin
cage assembly and autophagy of bacteria are interdependent, the
number of Shigella septin cages is significantly reduced following
siRNA knockdown of autophagymachinery components (Mostowy
et al., 2010; Mostowy et al., 2011). Moreover, Shigella mutants
lacking IcsB, a T3SS effector involved in autophagy evasion, are
compartmentalised into septin cages more efficiently than their
wild-type counterparts (Mostowy et al., 2010; Mostowy et al.,
2011). Importantly, ∼50% of Shigella entrapped in septin cages are
metabolically inactive, highlighting septin caging as an antibacterial
mechanism (Sirianni et al., 2016). In one of the first studies to use
zebrafish for investigation of bacterial autophagy in vivo (Mostowy
et al., 2013), infection of larvae with S. flexneri revealed that
autophagy is a crucial component of innate immunity at the whole-
organism level (Fig. 2D). In this case, depletion of the autophagy
receptor protein p62 significantly reduced septin cage-associated S.
flexneri, and increased bacterial burden and host mortality following
infection. How septin cages assemble and interact with other
cytoskeletal proteins during the autophagy response to bacteria, and
their ability to be manipulated for therapy, is currently the focus of
intense investigation.
Following T3SS-mediated invasion of epithelial cells, a number
of host cell mechanisms recruit the autophagy machinery to
Shigella, including the NLRs NOD1 and NOD2 that detect bacterial
peptidoglycan (see Glossary, Box 1) in the cytosol (reviewed in
Krokowski and Mostowy, 2016; Keestra-Gounder and Tsolis,
2017). NOD1/2 receptors can recruit ATG16L1, a protein crucial
for autophagosome (see Glossary, Box 1) development, and inhibit
the release of proinflammatory cytokines (Sorbara et al., 2013). A
separate autophagy pathway follows phagocytic rupture, in which
the autophagy machinery is recruited to damaged phagosomal
membranes labelled by ubiquitin (Dupont et al., 2009; Thurston
et al., 2012). In the cytosol, ATG5 interacts with the bacterial IcsA
and targets Shigella towards autophagy and septin caging (Ogawa
et al., 2005; Mostowy et al., 2010). A role for mitochondria in the
promotion of septin cage assembly and bacterial autophagy has also
been demonstrated (Sirianni et al., 2016). To avoid autophagic
destruction, actin-polymerising S. flexneri can fragment
mitochondria to counteract the assembly of septin cages (Sirianni
et al., 2016). Rapamycin, a pharmacological inhibitor of
mammalian target of rapamycin (mTOR; see Glossary, Box 1),
stimulates autophagy and has been proposed as a therapy to promote
bacterial clearance (Abdel-Nour et al., 2014). Indeed, in vitro
experimental work in a variety of cultured cell models has shown
that rapamycin can enhance the killing of bacteria (Gutierrez et al.,
2004; Tattoli et al., 2012). However, rapamycin treatment of S.
flexneri-infected zebrafish failed to rescue the infected hosts
(Mostowy et al., 2013), suggesting that therapeutic manipulation
of autophagy in vivo is complex. Similar results were observed
following rapamycin treatment of M. marinum-infected zebrafish,
which also failed to rescue the infected hosts (van der Vaart et al.,
2014).
Shigella-inflammasome interactions
In human (Zychlinsky et al., 1992) and zebrafish (Mostowy et al.,
2013) macrophages, Shigella infection induces cell death, yet the
underlying mechanisms are not fully understood. Interestingly,
targeted ablation of nascent macrophages in transgenic zebrafish
larvae Tg(mpeg1:Gal4-FF)gl25/Tg(UASE1b:nfsB.mCherry)c26 using
metronidazole (see Glossary, Box 1) decreased larval survival
following S. flexneri infection (Mazon-Moya et al., 2017),
indicating that macrophages can somehow protect against
infection in vivo. Experimental work performed in vitro using
cultured cell models has shown that Shigella can manipulate
inflammasome activity (reviewed in Hermansson et al., 2016;
Suzuki et al., 2017). Inflammasome-triggered cleavage of
interleukin (IL)-1β and IL-18 via cysteine-aspartic protease
(caspase)-1 (see Glossary, Box 1) recruitment results in
pyroptosis (see Glossary, Box 1; Miao et al., 2011). A variety of
exciting papers have used zebrafish to study inflammasome
activation in vivo. For example, clearance of S. Typhimurium
from zebrafish by neutrophils requires the interferon gamma (IFNγ)-
inducible GTPase guanylate-binding protein-4 (GBP-4; see
Glossary, Box 1) and the inflammasome-dependent production of
prostaglandin D2 (see Glossary, Box 1; Tyrkalska et al., 2016). In a
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separate study, zebrafish infection with a strain of Listeria
monocytogenes ectopically expressing flagellin, the principal
component of bacterial flagella, was shown to activate the
inflammasome in macrophages and decrease infection (Vincent
et al., 2016). Although tools to study the inflammasome in zebrafish
remain limited compared to mice, zebrafish can now be used to
follow the assembly of apoptosis-associated speck-like protein
containing a caspase-recruitment domain (ASC) specks (see
Glossary, Box 1) in vivo (Kuri et al., 2017). It will next be of
great interest to study the events and pathways underlying
inflammasome activation and cell death during Shigella infection
of zebrafish.
The host cytoskeletal components drive activation of the
inflammasome and cell-autonomous immunity (see Glossary,
Box 1; reviewed in Mostowy and Shenoy, 2015). Work has
linked actin to inflammation control through regulation of the
NACHT, LRR and PYD domain-containing protein 3 (NLRP3)
(Pelegrin and Surprenant, 2009; Jin et al., 2013; Johnson et al.,
2013) and pyrin inflammasome complexes (Kim et al., 2015;
Standing et al., 2017). Actin polymerisation proteins can regulate
the NLRP3 inflammasome by interacting with caspase-1 and other
inflammasome components (Pelegrin and Surprenant, 2009; Jin
et al., 2013; Johnson et al., 2013). Actin depolymerisation, as a
consequence of mutations in WD repeat-containing protein
(WDR1), can activate the pyrin inflammasome (Kim et al., 2015;
Standing et al., 2017). In the case of S. flexneri infection, disruption
of WASp results in increased inflammasome activity and decreased
bacterial clearance (Lee et al., 2017). Recent work using the
Shigella-zebrafish infection model has discovered a new role for
septins in inflammation control. Experiments in this study showed
that Sept15 morphants exhibit significantly increased caspase-1
activity and cell death, indicating that septins restrict inflammation
in vivo (Mazon-Moya et al., 2017). Considering that increased
inflammasome activity results in increased levels of IL-1β
(reviewed in Malik and Kanneganti, 2017), blocking IL-1β
signalling represents an attractive therapeutic solution to reduce
inflammation. Indeed, inflammation in Shigella-infected Sept15
zebrafish morphants can be dampened by treatment with anakinra,
an IL-1 receptor antagonist used to treat inflammatory disorders in
humans, which ultimately rescues neutrophil and host survival
(Mazon-Moya et al., 2017).
Together, these examples illustrate that zebrafish larvae are well
suited to study the breadth of cellular immune responses available to
control Shigella infection and inflammation. Moving forward, it can
be expected that studies using zebrafish will continue to identify the
molecular determinants and events underlying cellular immunity to
Shigella infection in vivo.
New ways to control Shigella infection
The Shigella-zebrafish infection model is highly versatile, and can
be used to illuminate novel research aiming to control bacterial
infection. In this section, we discuss how infection of zebrafish can
be used to investigate new concepts underlying infection control,
including emergency granulopoiesis and the use of predatory
bacteria to combat antimicrobial resistance.
Emergency granulopoiesis
How infection and inflammation can mediate emergency
granulopoiesis is a subject that is difficult to fully investigate
in vitro. The zebrafish model, however, has recently provided
valuable insights into the fundamental aspects of stem cell biology
and host defence. Haematopoiesis is the hierarchical process by
which haematopoietic stem and progenitor cells (HSPCs; see
Glossary, Box 1) produce mature blood cells (King and Goodell,
2011; Jagannathan-Bogdan and Zon, 2013; Laurenti and Göttgens,
2018). Following bacterial infection, circulating populations of
neutrophils can become exhausted. Although emergency
granulopoiesis can replenish the exhausted neutrophils, the
underlying molecular events are mostly unknown (Manz and
Boettcher, 2014; Teng et al., 2017). In the zebrafish, emergency
granulopoiesis takes place in the aorta-gonad-mesonephros (AGM)
and caudal hematopoietic tissue (CHT), and is supplied by the
proliferation and differentiation of HSPCs (Fig. 1). Strikingly, a
zebrafish model of S. Typhimurium infection revealed a direct
expansion of the HSPC niche in response to bacterial infection (Hall
et al., 2012). The HSPC expansion arises by release of
granulopoietic cytokines, including granulocyte colony-
stimulating factor (GCSF; CSF3) (Stachura et al., 2013).
Neutrophil expansion in the AGM and CHT is dependent on
inducible nitric oxide synthase (iNOS) and the transcription factor
CCAAT/enhancer-binding protein β (C/EBPβ) (Hall et al., 2012).
Considering that Shigella induces inflammation and neutropenia
during infection of zebrafish (Mazon-Moya et al., 2017), it will now
be of great interest to use Shigella infection of zebrafish to further
study HSPC signalling and emergency granulopoiesis, and their
precise role in host defence. An in-depth understanding of the
cellular and molecular mechanisms governing HSPC biology will
be important to inform strategies for using the therapeutic
manipulation of emergency granulopoiesis to treat bacterial
infections in humans. As a natural programme of host defence,
strategies to boost emergency granulopoiesis have great therapeutic
potential; however, such treatments must balance immune
stimulation with the risk of stem cell exhaustion.
Predatory bacteria work alongside the host immune cells to treat
Shigella infection
The emergence of antimicrobial resistant (AMR) bacteria is a global
health threat, and improved antimicrobial therapies are urgently
needed. The ESKAPE pathogens (Enterococcus faecium,
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter
baumannii, Pseudomonas aeruginosa and Enterobacter species)
are considered priority pathogens most likely to escape bactericidal
treatment (Boucher et al., 2009), and are also recognised as new
paradigms in microbial pathogenesis, transmission and resistance
(Pendleton et al., 2013). An increased understanding of these
pathogens can therefore lead to innovative strategies in the fight
against antibiotic-resistant infections. Bdellovibrio bacteriovorus
(see Glossary, Box 1) is a species of predatory bacteria gaining
recognition for its ability to invade and kill Gram-negative
pathogens (reviewed in Tyson and Sockett, 2017). Bdellovibrio
have great potential to be used as ‘living antibiotics’ because they
target pathogens using mechanisms that make acquiring resistance
to predation difficult. Work has shown that Bdellovibrio can predate
upon a wide variety of AMR Gram-negative bacteria in vitro
(Kadouri et al., 2013). However, despite our understanding of
bacterial predation in vitro, not much is known about the efficacy of
bacterial predation in vivo. A recent study examined Bdellovibrio
treatment following intranasal inoculation of rats with sublethal
doses of K. pneumoniae (Shatzkes et al., 2016). In this case, the
authors found a 2-log reduction in Klebsiella burden in the lungs of
the Bdellovibrio-treated rats. However, a follow-up study revealed
that exposure of Klebsiella-infected rats to successive rounds of
Bdellovibrio is ineffective against an acute blood infection
(Shatzkes et al., 2017). One caveat of using mammalian models is
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that it is difficult to visualise the predator-prey interactions in vivo.
To circumvent this, zebrafish larvae infected with multidrug
resistant Shigella were used to study Bdellovibrio predation
in vivo (Willis et al., 2016). This model system enabled, for the
first time, the visualisation of bacterial predator-prey interactions in
vivo in the presence or absence of an innate immune system (Fig. 3).
In this study, immunocompromised larvae were generated using a
morpholino targeting the transcription factor Pu.1 (Spi1b),
which prevents myeloid cell differentiation. Control and Pu.1
morphants were injected with a lethal dose of Shigella in the HBV
and treated with either phosphate buffered saline (PBS) or
Bdellovibrio (Willis et al., 2016). Enumerations of Shigella from
larval homogenates showed that treatment with Bdellovibrio
reduced Shigella numbers in both immunocompromised and
immunocompetent zebrafish larvae, but survival was significantly
greater in the immunocompetent larvae. These experiments
revealed that Bdellovibrio can work in synergy with the host
immune cells (macrophages and neutrophils) to clear Shigella
infection in vivo, before being cleared by the zebrafish immune
system themselves. Next, an in-depth investigation of Bdellovibrio
predation on a range of Gram-negative pathogens using the
zebrafish model is needed before ultimately translating this
procedure to higher vertebrates and humans.
Conclusions and emerging perspectives
Here, we have illustrated how the zebrafish model can be used to
study a variety of mechanisms underlying the host response to
Shigella infection. The Shigella-zebrafish infection model is
innovative because it is applicable to the in vivo milieu and
generalisable across infectious agents, thus facilitating the
comparison of evolutionarily distinct pathogens. In agreement
with this, lessons learned from Shigella infection of zebrafish can be
applied to other human bacterial pathogens (e.g. Listeria,
mycobacteria, Salmonella), and also to neglected pathogens (e.g.
Burkholderia, Rickettsia, Waddlia), of which little is known.
Furthermore, Shigella infection of zebrafish can reveal general
mechanisms of host defence relevant to combatting human infection
from viral and fungal pathogens.
As an emerging animal model for the study of Shigella infection,
the zebrafish offers numerous advantages and an exciting array of
cell biology applications. However, there are some limitations to
using the zebrafish model to study human bacterial infection. For
example, there is a demand for improved tools, such as zebrafish-
specific antibodies and knockout lines generated by CRISPR/Cas9.
Another potential caveat is temperature: the optimal zebrafish
growth temperature of 28°C mimics their natural environment, and
deviations from this can affect their developmental cycle, whereas
human pathogens are sometimes more virulent at 37°C, a
temperature that in zebrafish can cause a depressed immune
function and an upregulation of stress response proteins not present
at 28°C (Long et al., 2012; Lam et al., 2013). Although zebrafish
larvae offer the opportunity to study innate immunity in isolation,
they cannot enable studies involving adaptive immunity.
Experiments involving adaptive immunity will require the use of
adult zebrafish, which have been used to study a variety of
pathogenic bacteria, including M. marinum (Oehlers et al., 2015;
Cronan et al., 2016) and Mycobacterium leprae (see Glossary,
Box 1; Madigan et al., 2017). Lastly, the study of gene function in
zebrafish can be challenging owing to the presence of paralogues
(see Glossary, Box 1) within the genome (Howe et al., 2013).
However, paralogues arising from duplication events in the genome
can offer a redundancy, which can be beneficial for studies of genes
for which knockout might otherwise result in embryonic lethality.
Redundancy in the zebrafish genome has been beneficial to study a
Fig. 3. Interaction of the predatory bacteria Bdellovibriowith Shigella in the zebrafish. (A) Wild-type zebrafish larvae were injected in the hindbrain ventricle
(HBV) at 3 days postfertilisation with >5×103 colony forming units (CFUs) of GFP-S. flexneri (green), followed by hindbrain injection of either PBS or 1-2×105
plaque forming units (PFUs) of mCherry-Bdellovibrio (red), 30-90 min after the initialShigella infection. Representative images of the HBV in PBS- orBdellovibrio-
treated zebrafish larvae infected with Shigella are shown. The dashed line box shows the region of interaction between fluorescent Bdellovibrio and Shigella. For
both treatments, the same larva was imaged over time. Scale bar: 100 µm. hpi, hours postinfection. (B) Representative images of Shigella predation by
Bdellovibrio in vivo imaged by high-resolution confocal microscopy. Frames captured over time show stages of Bdellovibrio (red) invasive predation and rounding
of Shigella (green). Scale bar: 2.5 µm. mpi, minutes postinfection. Adapted from Willis et al. (2016).
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variety of genes crucial for host response to infection, including toll-
like receptors (TLRs) (reviewed in Kanwal et al., 2014), NLRs
(reviewed in Howe et al., 2016), and two Cxcl12 paralogues
functioning as chemokines to activate phagocytes (Boldajipour
et al., 2008).
As the Shigella-zebrafish model gains traction for the investigation
of infection and cellular microbiology in vivo, a number of inspiring
future directions are emerging (Box 2). Using this model, it will be of
great interest to perform global gene expression profiling during
infection for the discovery of new mechanisms underlying host
defence, and to screen pharmacological compounds for therapeutic
advance. To illuminate host-pathogen interactions, several interesting
transcriptomic (Stockhammer et al., 2009; Benard et al., 2016) and
proteomic (Díaz-Pascual et al., 2017) profiling studies have been used
in zebrafish infected with bacterial pathogens; similar approaches can
be used in zebrafish infected with Shigella. Moreover, ‘omics’ of
isolated cells (e.g. macrophages or neutrophils) infectedwith Shigella
can be illuminating to decipher bacterial virulence factors and host
defence mechanisms important during this interaction. Although
Shigella infection of adult zebrafish has not yet been tested, we
propose that adult zebrafish could be used to study the adaptive
immune response to Shigella, which is crucial to understanding the
crosstalk between Shigella and T lymphocytes (reviewed in Salgado-
Pabón et al., 2014) or to developing vaccine strategies (reviewed in
Phalipon et al., 2008; Mani et al., 2016).
Recent work using mixed bacterial cultures in vitro and in vivo
using rabbits and mice has shown that S. sonnei use a T6SS to
outcompete S. flexneri (Anderson et al., 2017). These results
highlight the T6SS as a key factor underlying the increasing
prevalence of S. sonnei in developing countries (Lima et al., 2015;
Kotloff et al., 2017), and will likely inspire the use of S. sonnei for
cellular microbiology studies using zebrafish. Originally discovered
in in vitro studies using Shigella infection of neutrophils, the release
of neutrophil extracellular traps (NETs; see Glossary, Box 1) is
currently regarded as an important cellular immunity mechanism for
controlling a variety of pathogens, including Staphylococcus,
Klebsiella, Aspergillus and Candida (Brinkmann et al., 2004;
Branzk et al., 2014; Storisteanu et al., 2017). It is tempting to
speculate that zebrafish infection models will be valuable to fully
dissect the role of NETs in host defence in vivo. Recent work has
shown in human cells (Wandel et al., 2017) and mice (Li et al.,
2017) that Shigella evades GBPs by releasing IpaH9.8, an E3
ubiquitin ligase (see Glossary, Box 1) that triggers GBP
degradation. Shigella infection of zebrafish can therefore be used
to study GBPs and their precise role in host defence in vivo.
The field of pathogenesis is evolving from focusing on the
mechanics of infection in vitro using cultured cells towards studying
the infection process in vivo using animal models. The crypt culture
model, known as intestinal organoids, is also powerful to study host-
pathogen interactions (Nigro et al., 2016) and the response of the
epithelium to enteric pathogens (Nigro et al., 2014). Considering the
versatility of zebrafish infection models, it can be predicted that our
understanding of Shigella pathogenesis will greatly benefit from in
vivo applications of genome editing (e.g. CRISPR/Cas9), high-
resolution imaging techniques (e.g. high-resolution fluorescence
microscopy and cryo-electron tomography), and automated high-
throughput screening approaches. Finally, it will be crucial that
advancements in infection and cell biology learned from Shigella
infection of zebrafish be applied for further study to higher
vertebrates, including humans, and also as a therapeutic avenue in
both human and veterinary medicine.
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